Guilherme A. Parise

Impact of Neonatal Screening and Surveillance for the <i>TP53</i> R337H Mutation on Early Detection of Childhood Adrenocortical Tumors

Gislaine Custódio, Guilherme A. Parise, Nilton Kiesel Filho et al. · Journal of Clinical Oncology · 2013 · 191 citations

Medicine, Oncology, Pediatrics +17

Mitotane Associated With Cisplatin, Etoposide, and Doxorubicin in Advanced Childhood Adrenocortical Carcinoma

Patrícia Zancanella, Mara Albonei Dudeque Pianovski, Brás Heleno de Oliveira et al. · Journal of Pediatric Hematology/Oncology · 2006 · 72 citations

Medicine, Oncology, Pharmacology +16

The Prognostic Role of CD8+ T Lymphocytes in Childhood Adrenocortical Carcinomas Compared to Ki-67, PD-1, PD-L1, and the Weiss Score

Ivy Z.S. Parise, Guilherme A. Parise, Lúcia de Noronha et al. · Cancers · 2019 · 34 citations · Full text

Medicine, Oncology, Pathology +17

High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation

Roberto Rosati, Flavia Cerrato, Mabrouka Doghman et al. · Cancer Genetics and Cytogenetics · 2008 · 28 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Penetrance of the TP53 R337H Mutation and Pediatric Adrenocortical Carcinoma Incidence Associated with Environmental Influences in a 12-Year Observational Cohort in Southern Brazil

Tatiana El Jaick Bonifácio Costa, Viviane K. Q. Gerber, Humberto C. Ibañez et al. · Cancers · 2019 · 27 citations · Full text

Medicine, Oncology, Pediatrics +17